(Q57554489)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

malignant pleural mesothelioma

16 January 2020

main subject

diagnosis

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Patrick Devos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Philippe Lassalle

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Arnaud Scherpereel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Bogdan Grigoriu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Thomas Gey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Marc Grégoire

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Marie-Christine Copin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Bachar Chahine

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Henri Porte

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

English

0 references

publication date

2 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory and Critical Care Medicine

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

1155-1160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Value of mesothelin immunostaining in the diagnosis of mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Application of Mesothelin Immunostaining in Tumor Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Expression of mesothelin mRNA in pure pancreatic juice from patients with pancreatic carcinoma, intraductal papillary mucinous neoplasm of the pancreas, and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Forced expression of deltaN-TCF-1B in colon cancer derived cell lines is accompanied by the induction of CEACAM5/6 and mesothelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Mesothelin: a new target for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Mesothelin-family proteins and diagnosis of mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Diagnosis and initial management of nonmalignant diseases related to asbestos

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Analysis of covariance using the rank transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Improving the utility of prostate specific antigen (PSA) in the diagnosis of prostate cancer: the use of PSA derivatives and novel markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

Role of osteopontin in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200511-1789OC

10.1164/RCCM.200511-1789OC

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16456138%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference